Airbus Zero-Emission Commercial Aircraft Models Achieve Key Capabilities, Says Globaldata

Following the announcement that Airbus plans to introduce zero-emission commercial aircraft models by 2035;

Harry Boneham, Aerospace and Defense Associate Analyst at GlobalData, a leading data and analytics company, offers his view:

“This announcement signals that Airbus recognizes the environmental impact of commercial aviation and is realigning to conform to a market in which consumers demand climate responsibility. It has been identified that zero-emission aircraft with a range of up to 1,200 nm will reduce airport NOx emissions by 60%, reduce fuel use and direct CO2 emissions by 40%, and account for 80% of all departures. Given that the capabilities of these models exceed this threshold, Airbus has positioned itself in a commanding position for the medium and long-term market.

“The three concept designs include a turbofan design, a turboprop design and a blended wing design. Of these models, the turbofan and blended wing designs have a passenger capacity of around 200 and a range of approximately 2000 nm, while the turboprop design can hold up to 100 passengers and has a range of approximately 1000 nm.

“Additionally, that the passenger capacity is comparable to contemporary narrow-body aircraft such as the A320neo and B737 MAX, is also encouraging. This will make for an easier transition from these older models to the zero-emission designs, as it will be a straight swap with little adaptation to fleet size and flight frequency necessary. In order not to lose market share, particularly in the narrow-body segment, Boeing must now develop its own low emission offerings. Ultimately, these developments are positive for the industry, pushing it in a direction which is sustainable and aligns with shifting passenger demand.”

Source: https://www.globaldata.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.